Author: Cameron Miller
-
Consortium to build sustainable pipeline of trials for new brain tumour therapies
A brain tumour consortium, funded by the National Institute for Health and Care Research (NIHR), with the vision to make the UK a “testbed for oncology innovation by accelerating the development of treatments for patients with brain tumours” is being developed and is aiming for real progress in “the soonest time frame possible.”
-
Rare Cancers Bill: How you can make a difference
Dr Scott Arthur MP’s Rare Cancers Bill aims to transform the rare cancers landscape. Your support would be a huge help in its success. Here’s how you can get involved.
-
Key takeaways from the Conservative manifesto launch 2024
We’ve taken a close look at the pledges made in the Conservative manifesto and what they could mean for people affected by a brain tumour.
-
Collaborating for change at the NICE conference 2023
We recently attended the NICE 2023 conference and share some of the key takeaways we gathered from the event.
-
Why we are supporting the Brain Tumour Research Petition for more funding into research
More research funding is essential for finding better treatments for brain tumours and ultimately helping people live longer and better. We outline why we are supporting the live petition on brain tumour research.
-
Potential new paediatric glioma treatment on the horizon
We will be working with NICE as they assess a new paediatric glioma treatment and ensuring the community has its voice heard as part of this process.
-
Widening the debate around treatment
We praise the launch of OurBrainBank’s new policy report and share how it ties in with our research strategy and innovations around treatment for glioblastomas.
-
The NHS Long Term Plan (for England) in review
Cameron, our Head of Policy and Public Affairs, discusses the detail contained within the NHS Long Term Plan and what it means for brain tumour patients in England.